Orthocell Ltd: Outstanding 98.6% Success Rate in Striate Implant Study
Orthocell Ltd: Compelling 85% Success Rate Remplir Study now published
Orthocell Ltd: Change of Director's Interest Notice-John Van Der Wielen
Orthocell Ltd: Change of Director's Interest Notice-John Van Der Wielen
Orthocell Ltd: Orthocell receives $3.05m R&D tax incentive refund
Orthocell Ltd: Quarterly Activity Report & Appendix 4C
Orthocell Ltd: Part 1 Remplir US Market Authorisation Successfully Complete
Orthocell Ltd: Trading Halt
Orthocell Ltd: Remplir Expansion Continues with Singapore Application
Orthocell Ltd: Quarterly Activity Report & Appendix 4C
Orthocell Ltd: Appendix 3Y - Kim Beazley
Orthocell Ltd: Final Director's Interest Notice
Orthocell Ltd: Initial Director's Interest Notice - Mr Kim Beazley
Orthocell Ltd: Final Director's Interest Notice
Orthocell Ltd: Change of Director's Interest Notice - Prof Fiona Wood
Orthocell Ltd: Change of Director's Interest Notice-John Van Der Wielen
Orthocell Ltd: Successful OrthoATI clinical trial
Orthocell Ltd: Change of Director's Interest Notice - Paul Anderson
Orthocell Ltd: Change of Director's Interest Notice-John Van Der Wielen
Orthocell Ltd: Initial Director's Interest Notice - Prof Fiona Wood
No Data